Abstract
Objectives: The most promising therapy for patients with advanced ischemic-heart disease is coronary-artery bypass grafting (CABG). The mainly used graft-materials are autologous saphenous-veins. However, they are prone to occlude at high rates, causing infarctions and the necessity for high-risk redo-surgery. Recently, a Nitinol-based external vein support mesh (eSVS™) was developed and tested in animals. It revealed superb patency and long-term lack of intimal hyperplasia in supported grafts. We report the first in-the-human implantations in patients undergoing CABG.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
